Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2015-03-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Blood Glucose Monitoring Devices With New Insight Features
NCT02929654
OneTouch® Verio™Pro+ Blood Glucose Monitoring System Clinical Accuracy Study in China
NCT01795625
The Evaluation of Laser Lancing Devices in Adult Type 2 Diabetes Patients
NCT05251506
Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm)
NCT00333853
Use of CoG by Patients With Diabetes Mellitus
NCT03840161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Verio Pattern Alert® activated
In this cohort, the patients will monitoring the glucose levels with capillar glucometer and they have activated the software Verio Pattern Alert® that could predict the glucose trends.
Verio Pattern Alert® activated
Verio Pattern Alert® deactivated
In this cohort, the patients will monitoring the glucose levels with capillar glucometer.
Verio Pattern Alert® deactivated
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Verio Pattern Alert® activated
Verio Pattern Alert® deactivated
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treatment with insulin regimen during at least 12 months
* Capability of performed 3 glucose measurement per day
* Levels of glycated hemoglobin (A1C) less than 10%
Exclusion Criteria
* Patients included in structured therapeutic health 6 months before the inclusion
* Patients included in any clinical trial in the 4 months before the inclusion
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación Pública Andaluza Progreso y Salud
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Complejo Hospitalario Universitario A Coruña
A Coruña, A Coruña, Spain
Hospital Universitario Torrecárdenas
Almería, Almería, Spain
Hospital Clínico San Carlos
Madrid, Madrid, Spain
Hospital Universitario Virgen de la Victoria
Málaga, Málaga, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECOVIQ
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.